Ratings by HSBC (Rajesh Kumar)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/3/2026 IQVIA Holdings IQV Maintain Buy
(N/A)
 
 
  Details
6/3/2026 Danaher DHR Maintain Buy
(N/A)
 
 
  Details
3/17/2026 Eli Lilly LLY Downgrade Reduce
(Hold)
985.08
(1111.60)
12.84% Details
3/10/2026 Pfizer PFE Maintain Buy
(N/A)
 
 
  Details
3/10/2026 Bristol-Myers Squibb Co. BMY Maintain Hold
(N/A)
 
 
  Details
3/10/2026 Biogen BIIB Maintain Reduce
(N/A)
 
 
  Details
12/10/2025 Biogen BIIB Downgrade Reduce
(Hold)
180.44
(198.59)
10.06% Details
12/10/2025 Abbvie ABBV Upgrade Buy
(Hold)
223.12
(231.59)
3.8% Details
12/1/2025 IQVIA Holdings IQV Maintain Buy
(N/A)
 
 
  Details
12/1/2025 Danaher DHR Maintain Buy
(N/A)
 
 
  Details
10/9/2025 IQVIA Holdings IQV Upgrade Buy
(Hold)
200.86
(167.54)
-16.59% Details
10/1/2025 Abbvie ABBV Downgrade Hold
(Buy)
231.54
(231.59)
0.02% Details
8/27/2025 Eli Lilly LLY Upgrade Hold
(Reduce)
736.03
(985.08)
33.84% Details
4/28/2025 Eli Lilly LLY Downgrade Reduce
(Buy)
859.73
(736.03)
-14.39% Details
4/28/2025 Biogen BIIB Downgrade Hold
(Buy)
119.51
(198.59)
66.17% Details
4/25/2025 IQVIA Holdings IQV Downgrade Hold
(Buy)
147.06
(200.86)
36.58% Details
12/4/2024 Novartis NVS Downgrade Reduce
(Hold)
104.56
(149.13)
42.63% Details
12/4/2024 Merck MRK Upgrade Buy
(Hold)
100.61
(115.22)
14.52% Details
12/4/2024 IQVIA Holdings IQV Maintain Buy
(N/A)
 
 
  Details
12/4/2024 Gilead Sciences GILD Maintain Hold
(N/A)
 
 
  Details
6/5/2024 Abbvie ABBV Upgrade Buy
(Hold)
160.19
(231.59)
44.57% Details
4/4/2024 UnitedHealth Group UNH Upgrade Hold
(Reduce)
459.74
(408.67)
-11.11% Details
12/18/2023 UnitedHealth Group UNH Downgrade Reduce
(Hold)
534.24
(408.67)
-23.5% Details
12/18/2023 Abbvie ABBV Downgrade Hold
(Buy)
154.88
(231.59)
49.53% Details
12/18/2023 Thermo Fisher Scientific TMO New Coverage Buy
(N/A)
521.52
(464.44)
-10.94% Details
12/18/2023 Teva Pharma TEVA New Coverage Buy
(N/A)
10.23
(32.14)
214.17% Details
12/18/2023 Danaher DHR New Coverage Hold
(N/A)
229.25
(179.10)
-21.88% Details
10/27/2023 Bristol-Myers Squibb Co. BMY Upgrade Hold
(Reduce)
56.61
(54.61)
-3.53% Details
9/15/2023 Bristol-Myers Squibb Co. BMY Maintain Reduce
(N/A)
 
 
  Details
7/14/2023 Sanofi-Aventis SNY New Coverage Buy
(N/A)
51.83
(41.59)
-19.76% Details